| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $2,068 | 1 | 25 |
Sells | $14,000 | 3 | 75 |
| AULT MILTON C III | director | 1 | $2,068 | 2 | $6,941 | $-4,874 |
| Horne William B. | director | 0 | $0 | 1 | $7,059 | $-7,059 |
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic …
Over the last 12 months, insiders at Alzamend Neuro Inc have bought $2,068 and sold $14,000 worth of Alzamend Neuro Inc stock.
On average, over the past 5 years, insiders at Alzamend Neuro Inc have bought $1.07M and sold $781,174 worth of stock each year.
Highest buying activity among insiders over the last 12 months: AULT MILTON C III (director) — $2,068.
The last purchase of 2,000 shares for transaction amount of $2,068 was made by AULT MILTON C III (director) on 2026‑04‑14.
| 2026-08-26 | Sale | AULT MILTON C III | director | 2,000 0.049% | $1.56 | $3,116 | -8.38% | |
| 2026-04-14 | AULT MILTON C III | director | 2,000 0.073% | $1.03 | $2,068 | +21.15% | ||
| 2025-12-23 | Sale | AULT MILTON C III | director | 1,851 0.058% | $2.07 | $3,825 | -33.82% | |
| 2025-12-19 | Sale | Horne William B. | director | 3,333 0.1065% | $2.12 | $7,059 | -35.07% | |
| 2025-10-09 | Sale | AULT MILTON C III | director | 20,397 0.6478% | $2.32 | $47,390 | -27.04% | |
| 2025-10-08 | Sale | AULT MILTON C III | director | 101,394 3.1113% | $2.44 | $247,158 | -32.02% | |
| 2025-10-07 | Sale | AULT MILTON C III | director | 57,379 1.8285% | $2.49 | $142,954 | -30.52% | |
| 2025-10-06 | Sale | AULT MILTON C III | director | 82,033 2.5039% | $2.45 | $201,268 | -32.42% | |
| 2025-10-03 | Sale | AULT MILTON C III | director | 65,903 2.153% | $2.44 | $160,889 | -30.24% | |
| 2025-10-02 | Sale | AULT MILTON C III | director | 20,686 0.6627% | $2.39 | $49,522 | -27.94% | |
| 2025-10-01 | Sale | AULT MILTON C III | director | 36,777 1.1559% | $2.35 | $86,378 | -27.35% | |
| 2025-09-30 | Sale | AULT MILTON C III | 3,566 0.1113% | $2.33 | $8,321 | -24.37% | ||
| 2025-09-29 | Sale | AULT MILTON C III | 38,324 1.1942% | $2.31 | $88,490 | -22.88% | ||
| 2025-09-26 | Sale | AULT MILTON C III | 37,738 1.1543% | $2.31 | $87,345 | -24.48% | ||
| 2025-09-25 | Sale | AULT MILTON C III | 14,628 0.4527% | $2.31 | $33,829 | -22.88% | ||
| 2025-09-24 | Sale | AULT MILTON C III | 39,140 1.2094% | $2.31 | $90,374 | -23.53% | ||
| 2025-09-23 | Sale | AULT MILTON C III | 43,238 1.3951% | $2.38 | $102,721 | -22.13% | ||
| 2025-09-19 | Sale | AULT MILTON C III | 77,009 2.4% | $2.35 | $180,856 | -23.96% | ||
| 2025-09-18 | Sale | AULT MILTON C III | 20,870 0.6586% | $2.47 | $51,493 | -26.51% | ||
| 2025-09-17 | Sale | AULT MILTON C III | 2,121 0.0663% | $2.45 | $5,204 | -26.80% |
| AULT MILTON C III | director | 0 0% | $0 | 109 | 29 | <0.0001% |
| Horne William B. | director | 0 0% | $0 | 3 | 1 | |
| Jackman Stephan | Chief Executive Officer | 45500 0.9429% | $66,430.00 | 1 | 0 | |
| McGrath Lynne Fahey | director | 10000 0.2072% | $14,600.00 | 1 | 1 | |
| Katzoff David J | Chief Financial Officer | 5540 0.1148% | $8,088.40 | 2 | 0 |
Alzamend Neuro, Inc. (ALZN) | $13,664,154 | 40 | -70.35% | $7.05M |
$29,645,465 | 28 | 8.09% | $6.48M | |
$63,749,694 | 24 | -12.24% | $6.4M | |
$287,718 | 15 | -41.45% | $5.68M | |
$812,698 | 12 | -57.09% | $7.89M |
| Increased Positions | 8 | +114.29% | 98,027 | +66.4% |
| Decreased Positions | <1 | -14.29% | <1 | <0.01% |
| New Positions | 3 | New | 43,052 | New |
| Sold Out Positions | <1 | Sold Out | <1 | Sold Out |
| Total Postitions | 14 | +100% | 245,648 | +66.4% |
| Drw Securities, Llc | $173.00 | 2.28% | 91,245 | +91,245 | New | 2025-09-30 |
| Vanguard Group Inc | $41.00 | 0.54% | 21,620 | +21,620 | New | 2025-09-30 |
| Geode Capital Management, Llc | $39.00 | 0.51% | 20,578 | +20,578 | New | 2025-09-30 |
| Clearstead Advisors, Llc | $19.00 | 0.25% | 10,000 | +10,000 | New | 2025-09-30 |
| Ubs Group Ag | $4.00 | 0.05% | 2,075 | +1,173 | +130.04% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $3.00 | 0.04% | 1,606 | +809 | +101.51% | 2025-09-30 |
| Blackrock, Inc. | $1.00 | 0.01% | 437 | -4 | -0.91% | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | <0.01% | 37 | +18 | +94.74% | 2025-09-30 |
| Sbi Securities Co., Ltd. | $0 | <0.01% | 22 | 0 | 0% | 2025-09-30 |
| Citigroup Inc | $0 | 0% | 1 | +<1 | New | 2025-09-30 |